ZA992899B - Novel compound. - Google Patents

Novel compound.

Info

Publication number
ZA992899B
ZA992899B ZA9902899A ZA992899A ZA992899B ZA 992899 B ZA992899 B ZA 992899B ZA 9902899 A ZA9902899 A ZA 9902899A ZA 992899 A ZA992899 A ZA 992899A ZA 992899 B ZA992899 B ZA 992899B
Authority
ZA
South Africa
Prior art keywords
novel compound
novel
compound
Prior art date
Application number
ZA9902899A
Other languages
English (en)
Inventor
Andrew Simon Craig
Alan David Jones
Deirdre O'keeffe
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA992899B publication Critical patent/ZA992899B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9902899A 1998-07-02 1999-04-23 Novel compound. ZA992899B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds

Publications (1)

Publication Number Publication Date
ZA992899B true ZA992899B (en) 2000-03-29

Family

ID=10834803

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA9902899A ZA992899B (en) 1998-07-02 1999-04-23 Novel compound.
ZA200100020A ZA200100020B (en) 1998-07-02 2001-01-02 Salts of paroxetine.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200100020A ZA200100020B (en) 1998-07-02 2001-01-02 Salts of paroxetine.

Country Status (21)

Country Link
EP (1) EP1091958A1 (cs)
JP (1) JP2002519421A (cs)
KR (1) KR20010053337A (cs)
CN (1) CN1314906A (cs)
AP (1) AP2000002017A0 (cs)
AU (2) AU4903999A (cs)
BG (1) BG105204A (cs)
BR (1) BR9911679A (cs)
CA (1) CA2336470A1 (cs)
CZ (1) CZ20004923A3 (cs)
EA (1) EA200100098A1 (cs)
GB (1) GB9814316D0 (cs)
HU (1) HUP0103712A3 (cs)
ID (1) ID27766A (cs)
IL (1) IL140385A0 (cs)
NO (1) NO20006547L (cs)
PL (1) PL345365A1 (cs)
SK (1) SK20242000A3 (cs)
TR (1) TR200100055T2 (cs)
WO (1) WO2000001692A1 (cs)
ZA (2) ZA992899B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2394782T3 (es) 2003-05-07 2013-02-05 Osteologix A/S Composición con estroncio y vitamina D para la profilaxis y/o tratamiento de afecciones de cartílagos y/o huesos
EP1745791B1 (en) 2003-05-07 2013-06-26 Osteologix A/S Treating cartilage/bone conditions with water-soluble strontium salts
CA2557324C (en) 2004-02-26 2012-10-16 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
EP1744770A2 (en) 2004-05-06 2007-01-24 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
KR100672184B1 (ko) 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
EP2046736B1 (en) 2006-07-27 2019-06-12 Emisphere Technologies, Inc. Arylsulfanyl compounds and compositions for delivering active agents
CN109212055B (zh) * 2018-08-19 2021-05-07 丁立平 一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法
CN109342633B (zh) * 2018-11-27 2020-10-02 北京市化工职业病防治院 尿液中苯、甲苯和二甲苯代谢物的检测方法
CN111337460B (zh) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 一种高稳定性Halo-tag探针及其合成和生物应用
CN116283778B (zh) * 2023-02-23 2025-08-29 江苏理工学院 一种吡唑羧酸类化合物及其制备方法和应用
US20250091996A1 (en) 2023-09-15 2025-03-20 King Faisal University 2-(1h-imidazole-1-carbonyl)benzoic acid as an anticancer compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
AU3108097A (en) * 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
CA2319652A1 (en) * 1998-02-06 1999-08-12 Michael Urquhart Salts of paroxetine

Also Published As

Publication number Publication date
CN1314906A (zh) 2001-09-26
BR9911679A (pt) 2002-01-29
JP2002519421A (ja) 2002-07-02
HUP0103712A3 (en) 2002-09-30
EP1091958A1 (en) 2001-04-18
HUP0103712A2 (hu) 2002-05-29
BG105204A (en) 2001-11-30
ZA200100020B (en) 2002-03-25
CZ20004923A3 (cs) 2001-08-15
NO20006547D0 (no) 2000-12-21
PL345365A1 (en) 2001-12-17
AU2002100370A4 (en) 2002-06-06
IL140385A0 (en) 2002-02-10
ID27766A (id) 2001-04-26
CA2336470A1 (en) 2000-01-13
EA200100098A1 (ru) 2001-08-27
AU4903999A (en) 2000-01-24
TR200100055T2 (tr) 2001-07-23
SK20242000A3 (sk) 2001-07-10
WO2000001692A1 (en) 2000-01-13
GB9814316D0 (en) 1998-09-02
NO20006547L (no) 2001-02-12
KR20010053337A (ko) 2001-06-25
AP2000002017A0 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
EG24814A (en) Novel compounds.
ZA996185B (en) Sulfanylsilanes.
ZA989767B (en) Novel compounds.
ZA200005136B (en) Dihydropyrimides.
GB9920332D0 (en) Novel compound
ZA991272B (en) Novel thiobenzamides.
ZA200005369B (en) Calcilytic compounds.
GB9805348D0 (en) Compound
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA994085B (en) Compound liquor.
ZA992899B (en) Novel compound.
GB9808268D0 (en) Compound
ZA993123B (en) Trisresorcinyltriazines.
ZA9811503B (en) Novel compounds.
ZA9811758B (en) Novel compounds.
GB9827431D0 (en) Novel compound
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA200006118B (en) Novel composition.
ZA98868B (en) Novel compounds.
ZA200000192B (en) Novel composition.
GB9808896D0 (en) Novel compound
ZA200201714B (en) Novel compound F-15078.
GB9808894D0 (en) Novel compound
ZA99985B (en) New compound.
ZA99942B (en) Novel compounds.